Sentinel Laboratory Response to Bioterrorism

Published on 08/02/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1588 times

Sentinel Laboratory Response to Bioterrorism

General Considerations

The practice of clinical microbiology changed significantly after Bacillus anthracis was intentionally released into the United States postal system in October 2001. Prior to this release there were two events in which microorganisms were used to intentionally harm the civilian population in the United States.

The first incident, in 1984, was a large community outbreak of salmonellosis caused by the intentional contamination of restaurant salad bars in The Dalles, Oregon. In this incident, a cult leader, Baghwan Sri Rajneesh, set out to influence the outcome of a local election by incapacitating voters. Cultures of Salmonella enterica Thyphimurium were grown at a laboratory within the cult’s compound. Ultimately, 751 individuals fell ill; luckily there were no deaths.

In 1996 an outbreak among laboratory workers was caused when a microbiology technologist in Dallas, Texas, purposely contaminated muffins and donuts with Shigella dysenteriae type 2. Forty-five laboratory workers developed gastroenteritis; four individuals were hospitalized.

The event in October 2001 stunned the country. Although there had previously been sporadic instances of suspicious letters, those events proved to be hoaxes. This outbreak resulted from the delivery of weaponized anthrax spores in mailed letters or packages; ultimately there were 11 cases of inhalational anthrax and 11 of cutaneous disease. Five individuals died. The attacks prompted institutions to implement or modify bioterrorism readiness plans. The United States government also reviewed the public health response and identified areas for improvement.

Government Laws and Regulations

The bombings at the World Trade Center in 1993 and the federal building in Oklahoma City in 1995 led Congress to pass the Antiterrorism and Effective Death Penalty Act of 1996. Section 511 (d) restricts the possession and use of materials capable of producing catastrophic damage in the hands of terrorists by requiring their registration. A companion law, the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001 prohibits any person to knowingly possess any biologic agent, toxin, or delivery system of a type or in a quantity that, under the circumstances, is not reasonably justified by prophylactic, protective, bona fide research, or other peaceful purpose. Later, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 required institutions to notify the Department of Health and Human Services (DHHS) or the United States Department of Agriculture (USDA) of the possession of specific pathogens or toxins called select agents. Therefore, clinical laboratories possessing any select agents must register with the Centers for Disease Control and Prevention (CDC), a branch of the DHHS. Violation of any of these statutes carries criminal penalties. The pathogens and toxins classified as select agents are listed in Box 80-1. List is updated as needed.

Bioterrorism agents are divided into three categories: A, B, or C. Category A agents are considered those presenting the highest risk to public health and national security because they are easily disseminated or transmitted from person to person and have high mortality rates. Category A includes pathogens such as Bacillus anthracis and Yersinia pestis. Category B agents are moderately easy to disseminate and have moderate to low mortality rates. This category includes Brucella species and Clostridium perfringens toxin. Category C contains emerging pathogens that could be engineered for mass spread in the future. Additional information may be found in Appendix F of the fifth edition of the CDC and the National Institutes of Health (NIH) manual Biosafety in Microbiological and Biomedical Laboratories (BMBL).

Biosecurity

Biosecurity is the latest issue of concern for microbiology laboratory directors and managers. Laboratories must conduct a risk assessment and threat analysis in order to write a security plan. This plan must include physical security (e.g., electronic card key access and locked freezers and refrigerators), and data system (laboratory information system) security and security policies for personnel.

Most hospital clinical laboratories have made a decision not to store any select agents. Some commercial laboratories, on the other hand, store select agents for use as positive controls for comparison with suspect samples. These laboratories must write standard operating procedures for (1) the access of select agents; (2) specimen accountability; (3) the receipt of select agents into the laboratory; (4) the transfer or shipping of select agents from the laboratory; (5) the reporting of incidents, injuries, and breaches of security; and (6) an emergency response plan if security is breached or the isolate is unintentionally released during an accident. They must also register the agents with the CDC.

Each clinical laboratory should have a bioterrorism response plan. The plan should include policies and procedures to be enacted when a suspicious isolate cannot be ruled out as a biothreat agent. If a laboratory has any questions about isolating, identifying, or submitting an organism that may be an agent of bioterrorism, laboratory personnel should call the state public health laboratory. The select agent must be either sent to a public health laboratory or destroyed within 7 days of identification. If the agent is autoclaved, its destruction must be documented using Animal and Plant Health Inspection Service (APHIS)/CDC Form 4, which can be downloaded at www.selectagents.gov/CDForm.html.

Laboratory Response Network

Laboratory testing and communication between clinical and public health laboratories is critical when responding to a bioterrorism event. To address this issue, the CDC, in partnership with the Association of Public Health Laboratories and the Federal Bureau of Investigation, established the Laboratory Response Network (LRN). The LRN is a three-tier system. Sentinel (formerly level A) laboratories receive patient samples, rule out pathogens, and transfer suspicious specimens to reference laboratories. References laboratories possess the required reagents and technology to perform confirmatory testing on pathogens. These labs may be local public health, military, international, veterinary, agriculture, food, or water testing laboratories. Confirmed bioterrorism agents are sent to a national laboratory. National laboratories, such as those at the CDC, U.S. Army Medical Research Institute for Infectious Diseases, or the Naval Medical Research Center, are responsible for the definitive characterization of agents (Figure 80-1).

Role of the Sentinel Laboratory

The main role of sentinel microbiology laboratories is to determine if a targeted agent is suspected in a human specimen. Detection and recognition of a possible bioterrorism event will depend on the following:

Sentinel laboratories must have a class II biologic safety cabinet, copies of level A protocols containing the algorithms for ruling out suspicious microorganisms (Table 80-1), and participate in an applicable proficiency testing program such as the College of American Pathologist’s Laboratory Preparedness Survey. Because sentinel laboratories rule out and refer microorganisms, proper knowledge of appropriate packaging and shipping is critical (see Chapter 4); all specimens must be classified as infectious. Sentinel laboratories should never accept nonhuman specimens such as those from animals or the environment. Such specimens should be submitted directly to the nearest reference laboratory.

May be mistaken for Haemophilus or Francisella Francisella tularensis

May be mistaken for Haemophilus or Actinobacillus Yersinia pestis Rapid systems may misidentify as Shigella spp., H2S-negative Salmonella spp., Acinetobacter spp., and Yersinia pseudotuberculosis Clostridium botulinum Send all specimens to reference laboratory; patient must get antitoxin immediately Smallpox and hemorrhagic fever viruses Smallpox can be mistaken for herpes virus if inoculated into routine tissue culture cells

image

*See individual chapters for a more detailed discussion of each organism.

Rapid communication between LRN sentinel members and their reference public health laboratories is essential. Each sentinel laboratory must know how to contact public health officials 24 hours/day. Sentinel laboratories, however, do not make the determination that a bioterrorist event has occurred and do not notify law enforcement. The Federal Bureau of Investigation (FBI) has primary responsibility when a bioterrorism event occurs as outlined in Presidential Decision Directive 39. A bioterrorist event is first and foremost a criminal investigation. The Federal Emergency Management Agency (FEMA) has the lead role in consequence management. FEMA receives assistance from the Department of Defense (DOD), Department of Energy (DOE), USDA, Department of Transportation (DOT), DHHS, and Environmental Protection Agency (EPA). FEMA, for example, calls for the deployment of the National Pharmaceutical Stockpile by the CDC so victims may be appropriately treated. Early recognition is the key to saving lives, and sentinel laboratorians are on the front lines in the fight against bioterrorism.

Because sentinel laboratories are charged with ruling out possible bioterrorism agents and referring suspicious isolates to reference laboratories for confirmatory testing, each sentinel laboratory’s bioterrorism response plan must include a telephone and pager number for the reference laboratory.

A sentinel laboratory’s key responsibility is to be familiar with likely agents involved in a biocrime; it must have standard operating procedures (SOPs) to accomplish this task. To standardize the process nationwide, the American Society for Microbiology (ASM) has compiled a series of guidelines. These guidelines are listed in Box 80-2 and may be accessed on the ASM website at www.asm.org/index.php/what-s-new-in-public-policy/sentinel-level-clinical-microbiology-laboratory-guidelines.html. Algorithms for the identification of likely bioterrorism agents are provided in Table 80-1.